Download and print as a PDF
DownloadIntravesical Chemotherapy is a treatment given into the bladder. It contains a drug that destroys abnormal and possible cancerous cells. It is described as a cytotoxic drug and its name is Mitomycin-C.
The treatment is a form of chemotherapy, but because it is given into the bladder and not the blood stream you should experience very few side effects as the drug stays inside your bladder and does not affect other parts of your body.
The treatment may cause some side effects; these are described later in more detail. The treatment can be given after specific operations e.g. Cystoscopy or Trans Urethral Resection of Bladder Tumour (TURBT). Alternatively you may need to have a course of treatment, usually once a week for six weeks. This will be as an outpatient. The treatment involves a small amount of fluid, containing the drug; being passed through a catheter, which is a fine hollow tube placed into your bladder and held there for one hour, this is to make sure that the fluid comes into contact with the whole of your bladder lining.
This will depend on how aggressive (grade) and how deep (stage) the bladder cancer is.
Approximately seven out of ten people with a superficial bladder cancer and / or carcinoma in situ will respond to treatment. These are cancers that affect the inner linings of the bladder wall.
Sometimes, even for those people who have had successful chemotherapy treatment, the bladder cancer may return and need to be removed again.
The treatment can be given immediately after your operation or as an outpatient. The treatment is given as an outpatient at the Princess Royal Hospital by a nurse trained in the procedure.
Most commonly, these include:
However, if they continue to last more than 3 days, then contact your G.P.
Less commonly:
Very uncommon
It is important that you see a doctor or go to the Accident & Emergency department if you develop any of these symptoms:
If you do see a Doctor, please let them know that you are receiving mitomycin treatment for bladder cancer.
Initial Mitomycin given post-operatively:
Date | Time | Comments | |
1 |
1st Mitomycin course
Date | Time | Comments | |
1 | |||
2 | |||
3 | |||
4 | |||
5 | |||
6 |
Next follow up: ________________________________________________________________
The Urology Nursing Team: 01444 441881 Extension 65457.
Email: uhsussex.urologyclinicalnursingteam@nhs.net
Urology Consultants:
Mr Coker’s secretary 01444 441881 Ext. 68043
Mr Crawford’s secretary 01444 441881 Ext. 65962
Mr Symes’ secretary 01273 696955 Ext. 67809
Mr Larner’s secretary 01273 696955 Ext. 67808
Mr Alanbuki’s secretary 01273 696955 Ext. 67810
Mr Zakikhani’s secretary 01273 696955 Ext. 67809
This information is intended for patients receiving care in Brighton & Hove or Haywards Heath.
The information here is for guidance purposes only and is in no way intended to replace professional clinical advice by a qualified practitioner.
Publication Date: March 2022
Review Date: December 2024